Cargando…
TGF-β Superfamily Receptors—Targets for Antiangiogenic Therapy?
The TGF-β pathway controls a broad range of cellular behavior including cell proliferation, differentiation, and apoptosis of various cell types including tumor cells, endothelial cells, immune cells, and fibroblasts. Besides TGF-β's direct effects on tumor growth and its involvement in neoangi...
Autores principales: | Otten, Jasmin, Bokemeyer, Carsten, Fiedler, Walter |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2871186/ https://www.ncbi.nlm.nih.gov/pubmed/20490264 http://dx.doi.org/10.1155/2010/317068 |
Ejemplares similares
-
Combination therapy targeting integrins reduces glioblastoma tumor growth through antiangiogenic and direct antitumor activity and leads to activation of the pro-proliferative prolactin pathway
por: Oliveira-Ferrer, Leticia, et al.
Publicado: (2013) -
TGFβ superfamily signaling and uterine decidualization
por: Ni, Nan, et al.
Publicado: (2017) -
Signal Processing in the TGF-β Superfamily Ligand-Receptor Network
por: Vilar, Jose M. G, et al.
Publicado: (2006) -
The role of FSH and TGF-β superfamily in follicle atresia
por: Chu, Yu-Lan, et al.
Publicado: (2018) -
Heparin, Heparan Sulphate and the TGF-β Cytokine Superfamily
por: Rider, Chris C., et al.
Publicado: (2017)